Literature DB >> 10648007

Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells.

A Klegeris1, P L McGeer.   

Abstract

Microglia become activated in a wide range of neurodegenerative disorders, including Alzheimer's disease. Such activation may lead to autodestruction of neurons. It is demonstrated here that activation of both human microglia and monocytic THP-1 cells by a combination of lipopolysaccharide and interferon-gamma results in secretion of neurotoxins that kill human neuronal SH-SY5Y cells. This neurotoxicity can be partially blocked by inhibitors of cytosolic phospholipase A2, cGMP-selective phosphodiesterases, or protein kinase C. When combinations of these inhibitors, or combinations of an inhibitor plus nordihydroguaiaretic acid, or the nonsteroidal anti-inflammatory drug diclofenac were tried, additive reductions in neurotoxicity were observed. It is concluded that the stimulants activated multiple intracellular pathways, and that combination therapies inhibiting these pathways might be beneficial for treating neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648007     DOI: 10.1002/jlb.67.1.127

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  16 in total

1.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 2.  Local neuroinflammation and the progression of Alzheimer's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

4.  Intravitreous delivery of the corticosteroid fluocinolone acetonide attenuates retinal degeneration in S334ter-4 rats.

Authors:  Inna V Glybina; Alexander Kennedy; Paul Ashton; Gary W Abrams; Raymond Iezzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-10       Impact factor: 4.799

5.  Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.

Authors:  Jessika Royea; Luqing Zhang; Xin-Kang Tong; Edith Hamel
Journal:  J Neurosci       Date:  2017-05-05       Impact factor: 6.167

6.  Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

Authors:  Kalpana J Kallianpur; Mariana Gerschenson; Brooks I Mitchell; Daniel E LiButti; Tracie M Umaki; Lishomwa C Ndhlovu; Beau K Nakamoto; Dominic C Chow; Cecilia M Shikuma
Journal:  Mitochondrion       Date:  2016-02-23       Impact factor: 4.160

Review 7.  HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases.

Authors:  D M Rausch; M R Davis
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

8.  Acidic fibroblast growth factor (FGF) potentiates glial-mediated neurotoxicity by activating FGFR2 IIIb protein.

Authors:  Moonhee Lee; Yunhee Kang; Kyoungho Suk; Claudia Schwab; Sheng Yu; Patrick L McGeer
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

9.  Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.

Authors:  Andis Klegeris; Christopher J Bissonnette; Patrick L McGeer
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

10.  Minocycline reduces intracerebral hemorrhage-induced brain injury.

Authors:  Jimin Wu; Shuxu Yang; Guohua Xi; Guosheng Fu; Richard F Keep; Ya Hua
Journal:  Neurol Res       Date:  2008-12-05       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.